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RANKL Regulates T Cells
Suppression of autoaggressive T cells by CD4+CD25+ regula-
tory T cells is important for maintaining peripheral tolerance 
and squelching autoimmune disease. Dendritic cells have been 
implicated as major players, but the regulation of CD4+CD25+ 
T cells is not completely understood. Loser and colleagues 
recently demonstrated that receptor activator of NF-κB (RANK) 
and the ligand, RANKL, are integral to this process. Expression 
of RANKL was upregulated in keratinocytes in response to 
inflammation and UV light. This increased expression resulted 
in an increase in the number of functional CD4+CD25+ regula-
tory T cells. More importantly, RANKL expression suppressed 
cutaneous contact hypersensitivity and CD40L-driven systemic 
autoimmunity. Interestingly, UV irradiation upregulated cuta-
neous RANKL, suggesting that UV-induced immunosuppres-
sion is mediated by the RANK–RANKL interaction. Hopefully, 
this new insight into CD4+CD25+ regulatory T cells will pave 
the way for the development of new therapeutic approaches 
for allergies and autoimmunity. (Nat Med 12:1372–9, 2006)
Gene Therapy for Epidermal 
Regeneration
Junctional epidermolysis bullosa (JEB) is a debilitating skin 
adhesion disorder caused by mutations in laminin 5 (LAM5), 
a component of the basement membrane. Mavilio and col-
leagues used a gene therapy strategy to treat a JEB patient. 
Cultured keratinocyte stem cells have been used previously 
to generate intact epithelium to treat skin and corneal defects. 
Thus, the patient’s keratinocytes, which were retrovirally 
transduced with LAM5-β3 cDNA, were used to generate epi-
dermal grafts. These grafts resulted in complete epidermal 
regeneration that persisted for the entire one-year study peri-
od. Notably, these genetically corrected grafts did not invoke 
a host inflammatory response. In addition, this clinical trial 
underscored the safety of gene therapy using Moloney leuke-
mia virus-derived retroviral vectors, as no clonal expansion or 
selection of the integration sites was noted. Successful gene 
therapy treatments herald potential relief for the more than 
500,000 people affected by epidermolysis bullosa. (Nat Med 
12:1397–402, 2006)
Keratin 10 Promotes Tumor Susceptibility
Keratins, which function in intermediate filament assembly, 
are composed of conserved rod domains and variable head 
and tail domains. In epidermal keratinocytes, keratin 10 (K10) 
has been implicated in cell-cycle control to promote terminal 
differentiation. To explore the role of K10 in proliferation and 
tumorigenesis, Chen and colleagues generated K10/K14 chi-
meric mice by fusing the K10 head and tail domains to the K14 
rod domain. Importantly, these chimeric mice expressed the 
K10 ends at physiological levels in keratinocytes. Contrary to 
previous work in cell culture and overexpression animal mod-
els, this chimeric protein did not alter epidermal proliferation 
or overall development. After exposure to a skin carcinogen-
esis protocol, these mice developed significantly more papil-
lomas than wild-type mice, suggesting a role for K10 ends in 
tumor susceptibility. In addition, chimeric keratinocytes exhib-
ited reduced apoptosis in response to UV radiation. Therefore, 
the authors speculated that K10 may temporally suppress cell 
death to allow completion of keratinocyte differentiation. 
(J Cell Sci 119:5067–76, 2006)
Epidermal Lipids Require GATA-3
As a functional epidermal barrier is essential in mammals for 
minimizing water loss and preventing entry of foreign agents 
into the organism, regulation of barrier development is a com-
plexly regulated process. Recently, de Guzman Strong and 
colleagues investigated the function of Gata-3, a transcrip-
tion factor that is expressed in the interfollicular epidermis. 
Epidermal-specific deletion of this gene revealed a specific 
defect in lipid synthesis that resulted in defective epidermal 
barrier formation and subsequent perinatal death. In addition, 
microarray analysis of the effects of GATA-3 deficiency at three 
stages of epidermal development (embryonic days 15.5 and 
16.5 and newborn) underscored a defect in lipid production 
and exposed defects in structural protein expression. As bar-
rier defects are the hallmarks of inflammatory skin disorders 
such as atopic dermatitis and psoriasis, the downstream com-
ponents of the implicated lipid biosynthesis pathway should 
be examined thoroughly to more clearly elucidate the role of 
GATA-3 in the regulation of epidermal barrier formation. (J Cell 
Biol 175:661–70, 2006)
Itch and Notch
Itch, an E3 ubiquitin ligase, is involved in generation of an 
autoimmune-like disease. In addition, this protein negatively 
regulates Notch signaling. Thus, Matesic and colleagues bred 
itch–/– mice with transgenic mice overexpressing the Notch1 
intracellular fragment, which functions as a transcriptional 
activator. Not only did the Notch1 transgenic mice develop 
autoimmune disease similar to that in itch–/– mice, but itch–/–; 
lck-Notch1 transgenic mice developed a more severe autoim-
mune phenotype with an earlier onset. These results are the first 
to indicate that Notch signaling is directly involved in autoim-
mune disease. Interestingly, a concomitant development of 
T-cell lymphomas and autoimmune disease in a subset of the 
itch–/–; lck-Notch1 transgenic mice mirrored previous clinical 
associations between autoimmunity and cancer. Understanding 
this link may indeed lead to better therapies for autoimmune 
diseases, which affect approximately 3% of the population. 
(Hum Mol Genet 15:3485–97, 2006)
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